- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 148.5M sh |
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $1.98B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.98B |
| Short Term Debt | Q1 2025 · Mar 29, 2025 | $8M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $6M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $577M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $692M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $1.58B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.79B |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $4.73B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.89B |
| Current Assets | Q1 2025 · Mar 29, 2025 | $3.06B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.17B |
| Total Assets | Q1 2025 · Mar 29, 2025 | $8.07B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.2B |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 148M sh |
| Capex | Q1 2025 · Mar 30, 2024 | $21M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $2M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $2.77B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.75B |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $0.29 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $0.29 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $231M |
| Rd Expense | Q1 2025 · Mar 30, 2024 | $25M |
| Net Income | Q1 2025 · Mar 30, 2024 | $43M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $128M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $400M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $1.09B |
| Revenue | Q1 2025 · Mar 30, 2024 | $1.49B |